Form 4: ICU Medical Inc. CEO Exercises and Sells Shares Under 10b5-1 Plan

ICU Medical's CEO, Vivek Jain, executed a pre-planned transaction involving the exercise of stock options and subsequent sale of shares on January 2, 2025.

Summary

• Vivek Jain, the Chairman and CEO of ICU Medical Inc., exercised 1,373 stock options at a price of $88.76 per share on January 2, 2025.
• Following the exercise, Mr. Jain sold 1,373 shares of common stock at a price of $155.48 per share on the same day.
• These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on March 15, 2024.
• After these transactions, Mr. Jain directly owns 104,593 shares and indirectly owns 88,698 shares through a trust.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction under a pre-arranged trading plan, with no indication of positive or negative sentiment. It is a neutral event.

Industry Context

This is a routine transaction for executives who use 10b5-1 plans to manage their stock holdings and avoid accusations of insider trading. It is common for executives to exercise options and sell shares for personal financial management.

Comparison to Industry Standards

• The use of 10b5-1 trading plans is a standard practice among publicly traded companies to allow insiders to trade shares without the risk of insider trading allegations.
• The exercise and sale of shares by the CEO is a common occurrence and is not unusual in the context of executive compensation and personal financial planning.
• The price at which the shares were sold is within the range of the market price at the time of the transaction.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale by an executive under a pre-arranged plan.

Key Dates

Keywords

ICU Medical, Vivek Jain, stock options, share sale, Rule 10b5-1, insider trading, executive compensation